GL1X · GenesisL1 explorer

MolNFT v1 · #109234 · protein

Crystal structure of human PI3K-gamma in complex with (S)-N-(1-(7- fluoro-2-(pyridin-2-YL)QUINOLIN-3-YL)ETHYL)-9H-purin-6-amine AMG319 inhibitor

4WWN · Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic…: “Crystal structure of human PI3K-gamma in complex with (S)-N-(1-(7…”. X-ray diffraction, 2 ligands (3VC, SO4), 12 pockets (best druggability 0.82). MolNFT v1 #109234 on…

PDB
4WWN
Type
protein
Length
831 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform
EC
2.7.1.153, 2.7.11.1
UniProt
P48736
Ligands
3VC, SO4
Pockets
12 · best druggability 0.82

Structure

x-ray diffraction · 1 distinct chain · 45% helix, 18% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
APhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform (EC 2.7.1.153, 2.7.11.1)protein83145% helix, 18% strandP48736

Ligands and binding sites

  • 3VC · N-{(1S)-1-[7-fluoro-2-(pyridin-2-yl)quinolin-3-yl]ethyl}-9H-purin-6-amine · ligand · chains A
  • SO4 · Sulfate ion · ion · 2 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

12 pockets found on a 1 Å grid, 6 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
111070.820.8374empty
22680.670.8333empty
33310.660.80413VC
41720.570.8126empty
52580.560.7740empty

Compared structures

  • 4WWN · Crystal structure of human PI3K-gamma in complex with… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.